These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27255375)

  • 21. Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation.
    Yadav NK; Nanda S; Sharma G; Katare OP
    AAPS PharmSciTech; 2017 Jul; 18(5):1863-1880. PubMed ID: 27844417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
    Jacob S; Nair AB; Al-Dhubiab BE
    J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
    Kumbhar D; Wavikar P; Vavia P
    AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
    Ramkanth S; Chetty CM; Sudhakar Y
    Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental optimization of Lornoxicam liposomes for sustained topical delivery.
    Joseph J; B N VH; D RD
    Eur J Pharm Sci; 2018 Jan; 112():38-51. PubMed ID: 29111151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
    Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S
    Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
    Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
    AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment.
    Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S
    AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Developments in Proniosomal Transdermal Drug Delivery: An Overview.
    Sabale V; Charde M; Dumore N; Mahajan U
    Curr Drug Deliv; 2023; 20(6):683-693. PubMed ID: 35466874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proniosomes as a Carrier System for Transdermal Delivery of Clozapine.
    Tareen FK; Shah KU; Ahmad N; Ur Rehman A; Shah SU; Ullah N
    Drug Dev Ind Pharm; 2020 May; ():1-24. PubMed ID: 32362194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application.
    Dasgupta S; Ghosh SK; Ray S; Kaurav SS; Mazumder B
    Curr Drug Deliv; 2014; 11(1):132-8. PubMed ID: 24266509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
    Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
    J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry Gel Containing Optimized Felodipine-Loaded Transferosomes: a Promising Transdermal Delivery System to Enhance Drug Bioavailability.
    Kassem MA; Aboul-Einien MH; El Taweel MM
    AAPS PharmSciTech; 2018 Jul; 19(5):2155-2173. PubMed ID: 29714001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
    Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
    Emad Eldeeb A; Salah S; Ghorab M
    Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.
    Varshosaz J; Pardakhty A; Baharanchi SM
    Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
    Rajabalaya R; Leen G; Chellian J; Chakravarthi S; David SR
    Pharmaceutics; 2016 Aug; 8(3):. PubMed ID: 27589789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.